Caffeine impairs intramuscular energy balance in patients susceptible to malignant hyperthermia

被引:5
|
作者
Textor, Z
Beer, M
Anetseder, M
Köstler, H
Kagerbauer, E
Kenn, W
Hahn, D
Roewer, N
机构
[1] Univ Wurzburg, Dept Anesthesiol, D-97080 Wurzburg, Germany
[2] Univ Wurzburg, Dept Radiol, Wurzburg, Germany
关键词
caffeine; diagnosis; energy metabolism; malignant hyperthermia; P-31-MRS;
D O I
10.1002/mus.10445
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Malignant hyperthermia (MH) is a metabolic myopathy with an abnormal release of calcium by the sarcoplasmic reticulum (SR), triggered by volatile anesthetics and succinylcholine. Similarly, caffeine enhances Ca2+ release by the SR in vitro. In a prospective, randomized study, high-energy phosphates were studied by intramuscular 31-phosphorus magnetic resonance spectroscopy (P-31-MRS) in 10 MH-susceptible (MHS) and 7 MH-nonsusceptible (MHN) subjects before and after injection of 0.5 ml caffeine (20 mM). Intramuscular energy balance, measured by the ratios of P-i/PCr and P-i/(gamma)-ATP, did not differ between MHS and MHN patients before and after intramuscular caffeine injection. However, within each group, P-i/PCr and P-i/(gamma)-ATP increased significantly only in the MHS group. Intramuscular caffeine injection seemed to impair the metabolic balance in MHS individuals. This may reflect a local calcium overload leading to consumption of high-energy phosphates and increase of inorganic phosphate. Intramuscular stimulation by caffeine and P-31-MRS may provide a valuable tool to investigate MH-related metabolic disturbances.
引用
收藏
页码:353 / 358
页数:6
相关论文
共 50 条
  • [21] Management of patients susceptible to malignant hyperthermia: A surgeon?s perspective
    Carlson, Kevin J.
    Sun, Sara A.
    Swan, Carol
    Koenig, Matthias
    Derkay, Craig S.
    INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2022, 159
  • [22] In-vitro effects of cocaine in malignant hyperthermia susceptible patients
    Weisshorn, R
    Wappler, F
    Scholz, J
    Fiege, M
    Esch, JSA
    ANESTHESIOLOGY, 1999, 91 (3A) : U216 - U216
  • [23] Safe duration of postoperative monitoring for malignant hyperthermia susceptible patients
    Pollock, N
    Langton, E
    Stowell, K
    Simpson, C
    McDonnell, N
    ANAESTHESIA AND INTENSIVE CARE, 2004, 32 (04) : 502 - 509
  • [24] ANESTHESIA IN A PATIENT SUSCEPTIBLE TO MALIGNANT HYPERTHERMIA
    SCHUH, FT
    MAIER, C
    ANAESTHESIST, 1982, 31 (05): : 245 - 247
  • [25] Management of malignant hyperthermia susceptible parturients
    Pollock, NA
    Langton, EE
    ANAESTHESIA AND INTENSIVE CARE, 1997, 25 (04) : 398 - 407
  • [26] Consensus guidelines on perioperative management of malignant hyperthermia suspected or susceptible patients from the European Malignant Hyperthermia Group
    Rueffert, Henrik
    Bastian, Boerge
    Bendixen, Diana
    Girard, Thierry
    Heiderich, Sebastian
    Hellblom, Anna
    Hopkins, Philip M.
    Johannsen, Stephan
    Snoeck, Marc M.
    Urwyler, Albert
    Glahn, Klaus P. E.
    BRITISH JOURNAL OF ANAESTHESIA, 2021, 126 (01) : 120 - 130
  • [27] EFFECTS OF CAFFEINE, HALOTHANE, SUCCINYLCHOLINE, PHENYLEPHRINE AND ISOPROTERENOL ON MYOCARDIAL FORCE OF CONTRACTION OF MALIGNANT HYPERTHERMIA SUSCEPTIBLE SWINE
    SCHOLZ, J
    ROEWER, N
    RUM, U
    SCHMITZ, W
    SCHOLZ, H
    ESCH, JSA
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1991, 35 (04) : 320 - 325
  • [28] ANALYSIS OF SARCOPLASMIC-RETICULUM PROTEINS IN PATIENTS SUSCEPTIBLE TO MALIGNANT HYPERTHERMIA
    OKU, S
    LIEW, CC
    BRITT, BA
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1983, 60 (01) : 127 - 135
  • [29] DEFICIENT FUNCTION OF THE SARCOPLASMIC-RETICULUM IN PATIENTS SUSCEPTIBLE TO MALIGNANT HYPERTHERMIA
    CONDRESCU, M
    LOPEZ, JR
    MEDINA, P
    ALAMO, L
    MUSCLE & NERVE, 1987, 10 (03) : 238 - 241
  • [30] SHOULD MALIGNANT HYPERTHERMIA-SUSCEPTIBLE PATIENTS UNDERGO MUSCLE BIOPSY
    HINKLE, AJ
    ANESTHESIOLOGY, 1994, 80 (03) : 708 - 708